Back to SYRE

MARSHALL WACE, LLP → SYRE

MARSHALL WACE, LLP SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
7
Latest value
$48.4M
Q3 2026
Peak value
$48.4M
First seen
Q4 2023

Dollar value over time

Show data table
PeriodPosition value
Q4 2023$436K
Q1 2024$6.1M
Q2 2026$17.3M
Q2 2026$33.9M
Q2 2026$36.9M
Q3 2026$15K
Q3 2026$48.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$48.4M544.0K——
Q3 2026$15K171——
Q2 2026$36.9M415.8K——
Q2 2026$33.9M381.4K——
Q2 2026$17.3M194.5K——
Q1 2024$6.1M161.9K——
Q4 2023$436K20.3K——

Other funds holding SYRE

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B